AI assistant
Edwards Lifesciences Corp — Director's Dealing 2015
Jun 1, 2015
30042_dirs_2015-06-01_6e243563-0911-43c4-9093-86fbc7488f3a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2015-05-13
Reporting Person: MUSSALLEM MICHAEL A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-13 | Common Stock | M | 7237.0000 | — | Acquired | 271087.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-13 | Performance Rights | $ | D | 966.0000 | Disposed | 2015-03-31 | Common Stock (966.0000) | Direct |
| 2015-05-13 | Performance Rights | $ | M | 7237.0000 | Disposed | 2015-03-31 | Common Stock (7237.0000) | Direct |
| 2015-05-13 | Performance Rights | $ | F | 7897.0000 | Disposed | 2015-03-31 | Common Stock (7897.0000) | Direct |
Footnotes
F1: On May 9, 2012, the reporting person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 13, 2015, 94% of the target shares vested and were issued and the balance of the award terminated. This amendment corrects the number of shares withheld for taxes and the number of shares acquired, which were initially incorrect due to an administrative error in calculating the number of shares withheld to cover taxes.
F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.